Vismodegib for adults with either Gorlin syndrome or non-Gorlin syndrome related multiple basal cell carcinomas. (Adults)
Vismodegib is recommended to be available as a treatment option through routine commissioning for adults with either Gorlin syndrome or non-Gorlin syndrome related multiple basal cell carcinomas within the criteria set out in the commissioning policy.
Source:
NHS England